Optima Coil System OPTI0408CSS10 (REF N/A)Recalls & reported problems
Balt USA LLC · The Optima Coil System is indicated for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations (AVMs) and arteriovenous fistulae. The Optima Coil System is also indicated for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolization in the peripheral vasculature. The Optima Coil System comprises of implant coil and a pusher assembly. The Optima Coil System is designed fr use with the XCEL Detachment Controller. The Optima coil is detached thermally with the XCEL Detachment Controller. · Class 2 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00818053025945), received between Jan 25, 2022 and Jul 30, 2024 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Premature Separation” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
3 other recalls cover devices cleared under the same FDA submission (K172390); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Jan 3, 2024Open, Classified
Discoloration was identified along the delivery pusher which was attributed to corrosion of the hypotube. The material which caused the corrosion was identified as remnants of solder flux residue remaining on the hypotube component of the delivery pusher. Due to the location of the delivery pusher within the delivery system, it is possible for the discoloration to mechanically break off from the delivery pusher, leaving the potential for the material to flow through the delivery system (i.e. microcatheter), and into the patient vasculature causing foreign emboli.
Z-1041-2024 · Root cause: Material/Component Contamination · FDA record ↗
Most reported problems
Device problems
- Premature Separation2
- Difficult or Delayed Separation1
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 30, 2024Migration; Difficult or Delayed Separation; Migration; Difficult or Delayed Separation
IT WAS REPORTED THAT: "A 48 YEARS OLD WOMAN WAS ADMITTED TO OUR CENTER TO EMBOLIZE A LEFT PARAOPTHLAMIC ANEURYSM WITH COILS. AFTER THE DEPLOYMENT OF THE FIRST FRAMING COIL (NON-OPTIMA COIL), A SECOND COIL (OPTIMA COMPLEX-10 SUPERSOFT 4X8 CM) WAS NAVIGATE INSIDE THE ANEURYSM WITH NO DIFFICULTIES. DESPITE OF THAT, WE COULD NOT DEPLOY THE COIL AFTER SEVERAL ATTEMPTS. AT THIS POINT, WE DECIDED TO REMOVE THE COIL, BUT AFTER REMOVE THE FIRST MM OF IT, THE WIRE WAS BROKEN AND THE COIL REMAINED RELEASED WITH A PART OUTSIDE THE ANEURYSM. THEREFORE, WE NAVIGATED A 0.014" MICROWIRE THROUGH THE MICROBALLOON TO TRY TO PACK THE COIL INSIDE THE ANEURYSM. HOWEVER, WE REALIZED THAT THE COIL STARTED TO MOVE BEFORE THE MICROWIRE ACHIEVE THE COIL, SO WE INTERPRETED THAT ACTUALLY THE COIL WAS BROKEN NOT IN THE INTERSECTION BETWEEN THE COIL AND THE WIRE, BUT RATHER SOME POINT ALONG THE WIRE OF THE COIL. FINALLY, WE ACHIEVED A COMPLETE OCCLUSION OF THE ANEURYSM WITH AN OPEN-CELL STENT AND 6 MORE COILS. THE PATIENT WOKE ASYMPTOMATIC WITH A MODERATE MIGRAINE AND SHE LEFT THE HOSPITAL 48 HOURS LATER WITHOUT NO OTHER INCIDENCES." UPDATE 10JUL2024 - ADDITIONAL INFORMATION RECEIVED FROM THE ISSUER: "1. DID THE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19862855 ↗MalfunctionJan 5, 2023Premature Separation; Premature Separation
IT WAS REPORTED THAT: "INDEED, THERE WAS AN UNCONTROLLED DETACHMENT (THE EQUIPMENT WAS RELEASED WITHOUT THE PLANNED DETACHMENT SYSTEM: BY THE ELECTRIC DETACHER). THE MATERIAL WAS THEREFORE FOUND INTRACRANIAL IN THE CEREBRAL ARTERIAL FLOW." 13DEC2022, ADDITIONAL INFORMATION PROVIDED BY ISSUER - TRANSLATION FRENCH TO ENGLISH: "- COULD YOU TELL US IF THIS INCIDENT WAS NOTIFIED TO THE ANSM? : YES. - COULD YOU TELL US HOW THE DOCTOR COMPLETED THE PROCEDURE? (USE OF A NEW COIL): THE DOCTOR RESORTED TO EMERGENCY ASPIRATION THROUGH A THROMBECTOMY CATHETER (SOFIA 6F) TO RETRIEVE THE COIL. - COULD YOU TELL US IF THE DOCTOR CARRIED OUT AN ADDITIONAL INTERVENTION? : THE DOCTOR HAS STOPPED THE INTERVENTION. ISSUER CONFIRMED NO PATIENT INJURY WAS SUSTAINED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16103368 ↗MalfunctionJan 25, 2022Premature Separation; Premature Separation
IT WAS REPORTED THAT: "AFTER USING IT AS THE FIRST FRAME, THE BASKET COULD NOT BE FORMED WELL, SO WHEN REMOVING THE COIL, THE COIL DID NOT MOVE. WHEN CHECKED IT WAS FOUND THAT IT WAS PRE-DETACHED. THE PROFESSOR WAS FLUSTERED BECAUSE IT BROKE EASILY AFTER PUSHING IT IN AND OUT ONLY ONCE OR TWICE. FORTUNATELY, THE COIL WAS RETRIEVED BY SNARE AND RECOVERED, BUT PUSHER COULD NOT BE RECOVERED."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13345107 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K172390. One submission often covers many models, so check the product and lot details in each record.
- Z-1988-2025 · May 8, 2025 · Open, ClassifiedOptima Coil System REFs/UDI-DI codes: OPTI0156BLK 00810068568875 OPTI0158BLK 00810068568882 OPTI0103BLK 00810068568851 OPTI0258BLK 00810068568929 OPTI0212BLK 00810068568912 OPTI020
- Z-0103-2023 · Sep 7, 2022 · Open, ClassifiedOptima Coil System Model Number OPTI0208CSS10, Model Number OPTI0308CSS10. Used in endovascular procedures.
- Z-1680-2022 · Jul 26, 2022 · Open, ClassifiedOptima Coil System Model OPTI0520CSF10. For endovascular embolization.
Other Device, Neurovascular Embolization devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page